Insider Trading Alert - IPG, IVC And KTEC Traded By Insiders

Yesterday, May 3, 2016, 71 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $503.53 to $7,621,855.35. Highlighted Stocks Traded by Insiders: Interpublic Group of Companies (IPG) - FREE Research Report Carroll Christopher F, who is SVP, Controller & CAO at Interpublic Group of Companies, sold 20,000 shares at $23.33 on May 3, 2016. Following this transaction, the SVP, Controller & CAO owned 39,285 shares meaning that the stake was reduced by 33.74% with the 20,000-share transaction. The shares most recently traded at $23.34, up $0.01, or 0.03% since the insider transaction. Historical insider transactions for Interpublic Group of Companies go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 22,700
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 36,654
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 36,654
The average volume for Interpublic Group of Companies has been 4.6 million shares per day over the past 30 days. Interpublic Group of Companies has a market cap of $9.4 billion and is part of the services sector and media industry. Shares are up 0.13% year-to-date as of the close of trading on Tuesday. The Interpublic Group of Companies, Inc. provides advertising and marketing services worldwide. It operates through two segments, Integrated Agency Networks and Constituency Management Group. The stock currently has a dividend yield of 2.57%. The company has a P/E ratio of 20.8. Currently, there are 6 analysts who rate Interpublic Group of Companies a buy, no analysts rate it a sell, and none rate it a hold. Exclusive Offer: Get the latest Stock Analysis on IPG - FREE TheStreet Quant Ratings rates Interpublic Group of Companies as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, solid stock price performance, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full Interpublic Group of Companies Ratings Report from TheStreet Quant Ratings now. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Invacare (IVC) - FREE Research Report Monaghan Matthew E., who is Chairman, President and CEO at Invacare, bought 4,500 shares at $11.39 on May 3, 2016. Following this transaction, the Chairman, President and CEO owned 140,455 shares meaning that the stake was boosted by 3.31% with the 4,500-share transaction. The shares most recently traded at $11.18, down $0.21, or 1.88% since the insider transaction. Historical insider transactions for Invacare go as follows:

  • 4-Week # shares bought: 13,200
  • 4-Week # shares sold: 1,000
  • 12-Week # shares bought: 13,200
  • 12-Week # shares sold: 1,000
  • 24-Week # shares bought: 13,200
  • 24-Week # shares sold: 1,000
The average volume for Invacare has been 570,200 shares per day over the past 30 days. Invacare has a market cap of $371.3 million and is part of the health care sector and health services industry. Shares are down 36.98% year-to-date as of the close of trading on Tuesday. Invacare Corporation designs, manufactures, and distributes medical equipment for use in home health care, retail, and extended care markets. It operates through four segments: North America/Home Medical Equipment, Institutional Products Group, Europe, and Asia/Pacific. The stock currently has a dividend yield of 0.44%. The company has a P/E ratio of 14.8. Currently, there is 1 analyst who rates Invacare a buy, no analysts rate it a sell, and none rate it a hold. Exclusive Offer: Get the latest Stock Analysis on IVC - FREE TheStreet Quant Ratings rates Invacare as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, poor profit margins, weak operating cash flow and generally disappointing historical performance in the stock itself. Get the full Invacare Ratings Report from TheStreet Quant Ratings now. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Key Technology (KTEC) - FREE Research Report PVAM Perlus Microcap Fund, L.P., who is 10% Owner at Key Technology, bought 300 shares at $8.60 on May 3, 2016. Following this transaction, the 10% Owner owned 697,859 shares meaning that the stake was boosted by 0.04% with the 300-share transaction. The shares most recently traded at $9.50, up $0.90, or 9.47% since the insider transaction. Historical insider transactions for Key Technology go as follows:

  • 4-Week # shares bought: 13,207
  • 4-Week # shares sold: 1,000
  • 12-Week # shares bought: 21,555
  • 12-Week # shares sold: 1,000
  • 24-Week # shares bought: 26,934
  • 24-Week # shares sold: 1,000
The average volume for Key Technology has been 14,600 shares per day over the past 30 days. Key Technology has a market cap of $55.5 million and is part of the industrial goods sector and industrial industry. Shares are down 12.83% year-to-date as of the close of trading on Tuesday. Key Technology, Inc., together with its subsidiaries, designs, manufactures, sells, and services process automation systems integrating electro-optical inspection, sorting, and process systems in the United States and internationally. Currently, there are no analysts who rate Key Technology a buy, no analysts rate it a sell, and none rate it a hold. Exclusive Offer: Get the latest Stock Analysis on KTEC - FREE TheStreet Quant Ratings rates Key Technology as a sell. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, poor profit margins and generally disappointing historical performance in the stock itself. Get the full Key Technology Ratings Report from TheStreet Quant Ratings now. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Here's Why Alphabet, Facebook and Amazon Earnings May Overshadow Tariff Worries

Here's Why Alphabet, Facebook and Amazon Earnings May Overshadow Tariff Worries

NYSE Trader Expects Blowout Earnings From Alphabet, Amazon and Facebook

NYSE Trader Expects Blowout Earnings From Alphabet, Amazon and Facebook

Don't Panic! The Risk of a Recession This Year Is Low

Don't Panic! The Risk of a Recession This Year Is Low

Even Standing Desk Company Varidesk Is Watching How the Trump Tariffs Play Out

Even Standing Desk Company Varidesk Is Watching How the Trump Tariffs Play Out

State Street Gets Pummeled on Software Deal; Pizza Wars Are Raging -- ICYMI

State Street Gets Pummeled on Software Deal; Pizza Wars Are Raging -- ICYMI